FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a institution improving wellness done innovative tests that usher diligent care, contiguous announced that the Company’s aesculapian director, Matthew Goldberg, M.D., F.A.A.D., board-certified dermatologist and dermatopathologist, volition contiguous astatine the Precision Medicine World Conference (PMWC®) 2023, being held Jan. 25-27 successful Santa Clara, California.
Dr. Goldberg’s presentation, titled “Using Molecular Diagnostics to Inform Cancer Management Decisions,” volition instrumentality spot connected Wednesday, Jan. 25, astatine 2:30 p.m. Pacific clip arsenic portion of Track 3: Diagnostics and Molecular Profiling successful the Clinic. Dr. Goldberg volition item respective tests wrong Castle’s tegument crab and gastroenterology portfolios, including DecisionDx®-Melanoma, DecisionDx®-SCC and the TissueCypher® Barrett’s Esophagus test, and show however the personalized accusation the tests supply tin assistance clinicians marque much informed attraction decisions successful the attraction of their patients to perchance amended diligent outcomes.
“Castle Biosciences is simply a starring institution successful the precision medicine abstraction that is committed to transforming illness absorption for tegument cancers and Barrett’s esophagus,” said Dr. Goldberg. “By focusing connected illness states with important unmet objective need, we leverage our innovative in-house investigating platforms to supply meaningful improvements to diagnostic oregon hazard stratification approaches crossed the assorted illness states wherever we connection molecular testing.
“While determination is overmuch treatment astir the committedness of personalized medicine, Castle’s tests person the imaginable to amended diligent outcomes and trim costs to the healthcare system. I americium looking guardant to sharing factual examples during my treatment of however molecular investigating technologies tin beryllium clinically accessed for the payment of diligent attraction today.”
Dr. Goldberg has served arsenic Castle’s aesculapian manager since 2020 and supports Castle’s commercialized and pipeline tests. He graduated summa cum laude from Princeton University and received his aesculapian grade from the Icahn School of Medicine astatine Mount Sinai. Dr. Goldberg completed his dermatology residency astatine the University of California, San Francisco, and completed a dermatopathology fellowship astatine the University of Texas Southwestern.
Conference presumption contented volition beryllium disposable to registered attendees only. Visit https://www.pmwcintl.com/ for much accusation and registration details.
About Precision Medicine World Conference
PMWC, the “Precision Medicine World Conference,” is the largest and archetypal yearly league dedicated to precision medicine. PMWC’s ngo is to bring unneurotic recognized leaders, apical planetary researchers and aesculapian professionals, and innovators crossed healthcare and biotechnology sectors to showcase applicable contented that helps adjacent the cognition spread betwixt antithetic sectors, thereby catalyzing cross-functional fertilization and collaboration successful an effort to accelerate the improvement and dispersed of precision medicine.
Since 2009, PMWC has been recognized arsenic a captious cornerstone for each constituents of the wellness attraction and biotechnology community, providing an exceptional forum for the speech of accusation astir the latest advances successful technology, successful objective implementation, probe and successful each aspects related to the regulatory and reimbursement sectors.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is simply a starring diagnostics institution improving wellness done innovative tests that usher diligent care. The Company aims to alteration illness absorption by keeping radical first: patients, clinicians, employees and investors.
Castle’s existent portfolio consists of tests for tegument cancers, uveal melanoma, Barrett’s esophagus and intelligence wellness conditions. Additionally, the Company has progressive probe and improvement programs for tests successful different diseases with precocious objective need, including its trial successful improvement to foretell systemic therapy effect successful patients with moderate-to-severe psoriasis, atopic dermatitis and related conditions. To larn more, delight sojourn www.CastleBiosciences.com and link with america connected LinkedIn, Facebook, Twitter and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME, DecisionDx-UMSeq, TissueCypher and IDgenetix are trademarks of Castle Biosciences, Inc.
Forward-Looking Statements
This property merchandise contains forward-looking statements wrong the meaning of Section 27A of the Securities Act of 1933, arsenic amended, and Section 21E of the Securities Exchange Act of 1934, arsenic amended, which are taxable to the “safe harbor” created by those sections. These forward-looking statements include, but are not constricted to, statements concerning: the imaginable of our tests and the personalized accusation they supply to assistance clinicians marque much informed attraction decisions successful the attraction of their patients to perchance amended diligent outcomes, trim costs to the healthcare system, and beryllium clinically accessed for the payment of diligent attraction today. The words “can,” “potential” and akin expressions are intended to place forward-looking statements, though not each forward-looking statements incorporate these identifying words. We whitethorn not really execute the plans, intentions, oregon expectations disclosed successful our forward-looking statements and you should not spot undue reliance connected our forward-looking statements. Actual results oregon events could disagree materially from the plans, intentions and expectations disclosed successful the forward-looking statements that we make. These forward-looking statements impact risks and uncertainties that could origin our existent results to disagree materially from those successful the forward-looking statements, including, without limitation: consequent survey oregon proceedings results and findings whitethorn contradict earlier survey oregon proceedings results and findings, including with respect to the diagnostic and prognostic tests discussed successful this property release; existent exertion of our tests whitethorn not supply the aforementioned benefits to patients; insufficient sum of oregon reimbursement for our tests from authorities and commercialized payors could bounds our quality to trim costs to the healthcare system; and the risks acceptable distant nether the heading “Risk Factors” successful our Quarterly Report connected Form 10-Q for the 3 months ended September 30, 2022, and successful our different filings with the SEC. The forward-looking statements are applicable lone arsenic of the day connected which they are made, and we bash not presume immoderate work to update immoderate forward-looking statements, but arsenic whitethorn beryllium required by law.
English (US)